| 000 | 01846 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513213605.0 | ||
| 264 | 0 | _c20000828 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/s0091-3057(00)00189-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCasas, M | |
| 245 | 0 | 0 |
_aMethylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cJun 2000 |
||
| 300 |
_a257-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 |
_aCaffeine _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDextroamphetamine _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aDrinking _xdrug effects |
| 650 | 0 | 4 |
_aEating _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeural Pathways _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aQuinpirole _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 |
_aSulpiride _xpharmacology |
| 650 | 0 | 4 | _aSyndrome |
| 650 | 0 | 4 |
_aTheophylline _xpharmacology |
| 650 | 0 | 4 |
_aXanthines _xpharmacology |
| 700 | 1 | _aPrat, G | |
| 700 | 1 | _aRobledo, P | |
| 700 | 1 | _aBarbanoj, M | |
| 700 | 1 | _aKulisevsky, J | |
| 700 | 1 | _aJané, F | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 66 _gno. 2 _gp. 257-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0091-3057(00)00189-1 _zAvailable from publisher's website |
| 999 |
_c10831258 _d10831258 |
||